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Activation of focal adhesion kinase (FAK) is known to protect heart muscle against ischemia reperfusion (IR)
injury. It is shown that IR-induced rhabdomyolysis, macrophage inﬁltration, and apoptosis of skeletal muscle are
ﬁber type-speciﬁc phenomena graded by mitochondria reserves. Moreover, over expression of FAK protected
fast skeletal muscle against IR injury by exploiting these reserves, possibly resulting in reduced tissue loss during
IR. These ﬁndings may lead to novel therapeutic approaches to acute limb ischemia.Objectives: In cardiac muscle, ischemia reperfusion (IR) injury is attenuated by mitochondrial function, which
may be upregulated by focal adhesion kinase (FAK). The aim of this study was to determine whether increased
FAK levels reduced rhabdomyolysis in skeletal muscle too.
Material and methods: In a translational in vivo experiment, rat lower limbs were subjected to 4 hours of
ischemia followed by 24 or 72 hours of reperfusion. FAK expression was stimulated 7 days before (via somatic
transfection with pCMV-driven FAK expression plasmid) and outcomes were measured against non-transfected
and empty transfected controls. Slow oxidative (i.e., mitochondria-rich) and fast glycolytic (i.e., mitochondria-
poor) type muscles were analyzed separately regarding rhabdomyolysis, apoptosis, and inﬂammation. Severity of
IR injury was assessed using paired non-ischemic controls.
Results: After 24 hours of reperfusion, marked rhabdomyolysis was found in non-transfected and empty plasmid-
transfected fast-type glycolytic muscle, tibialis anterior. Prior transfection enhanced FAK concentration
signiﬁcantly (p ¼ 0.01). Concomitantly, levels of BAX, promoting mitochondrial transition pores, were reduced
sixfold (p ¼ 0.02) together with a blunted inﬂammation (p ¼ 0.01) and reduced rhabdomyolysis (p ¼ 0.003).
Slow oxidative muscle, m. soleus, reacted differently: although apoptosis was detectable after IR, rhabdomyolysis
did not appear before 72 hours of reperfusion; and FAK levels were not enhanced in ischemic muscle despite
transfection (p ¼ 0.66).
Conclusions: IR-induced skeletal muscle rhabdomyolysis is a ﬁber type-speciﬁc phenomenon that appears to be
modulated by mitochondria reserves. Stimulation of FAK may exploit these reserves constituting a potential
therapeutic approach to reduce tissue loss following acute limb IR in fast-type muscle.
 2014 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. All rights
reserved.
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Acute limb ischemia is among the most common peripheral
vascular emergencies.1,2 It threatens tissue viability even
after a relatively short insult by ischemia reperfusion (IR)
associated inﬂammation and rhabdomyolysis.3 Apoptotic
cell death is a programmed, energy dependent process,
which is believed to play a pivotal role in the tissue
response to IR. A variety of death signals including calcium
overload4 may trigger apoptosis or inﬂammation via tran-
sition pore-mediated destruction of mitochondria (Fig. 1A).
Bcl-2 family molecules, such as BAX and Blc-2, which either
promote or inhibit transition pore opening, exert a critical
role on whether a cell will live or die.5 The involvement of
Figure 1. (A) Mechanisms of ischemia reperfusion damage and salvage and experimental protocol. RISK refers to a group of pro-survival
protein kinases (FAK, AKT, and p70S6K) that confer muscle protection. During the ﬁrst few minutes of reperfusion, a cellular increase in
Ca2þ occurs which can be partially buffered by mitochondria. At a critical threshold, however, opening of permeability transition pores leads
to cell death, either through energy dependent apoptosis, being fuelled by mitochondrial ATP production, or through necrosis. Fast-type
muscle ﬁbers have a lower mitochondrial content than slow-type muscle ﬁbers and are more susceptible to IR injury. Endpoints, which
were assessed using markers, are underlined and the factors being modulated experimentally are highlighted in color. (B) Experimental
design. IR injury was evaluated following 4 hours of ischemia and 24 hours or 72 hours of reperfusion (n ¼ 6 animals). Contralateral limbs
served as paired controls, as represented by the double headed arrow. External controls were subjected to ischemia only (n ¼ 2) or sham-
treatment (n ¼ 4). The effects following transfection with expression plasmid for FAK (pCMV-FAK) were compared with empty plasmid
transfection (pCMV) (n ¼ 13 animals). AKT ¼ serine/threonine protein kinase AKT; BAX ¼ apoptosis regulator BAX; Bcl-2 ¼ apoptosis
regulator Bcl-2; FAK¼ focal adhesion kinase; IR¼ ischemia reperfusion; MTP¼mitochondria transition pore; p70S6K¼ ribosomal S6kinase;
RISK ¼ reperfusion induced salvage kinase. Note: The concept of ischemia and reperfusion injury was modiﬁed from refs 4,9,14.
Protective Effect of Focal Adhesion Kinase 307mitochondria may explain why the degree of ﬁber injury
has been found to vary between contractile muscle phe-
notypes.6 Slow-type ﬁbers generally have a higher mito-
chondria content than fast-type muscle. Mitochondria may
act as a buffer against lethal calcium overload and fuel the
energy dependent processes of apoptotic programming and
self contained removal of cell debris. This may limit
inﬂammation and lysis of damaged muscle ﬁbers (Fig. 1A)
and explain why fast-type muscle ﬁbers are more prone to
IR injury.
In the heart, anti-apoptotic signaling cascades, collec-
tively referred to as the reperfusion injury salvage kinase
(RISK) pathway, have gained much interest in acute
myocardial infarction.7e10 Among other effects, RISK leads
to suppressed BAX action and prevents mitochondrial
destruction.4,5,9 So far, the therapeutic potential of this
pathway has not been established in peripheral skeletal
muscle. Modulation of focal adhesion kinase (FAK) offers
one potential approach (Fig. 1A). FAK modulates integrin-
based cell to cell matrix junctions that link the extracel-
lular matrix to the cytoskeleton, which is key for main-
taining tissue integrity, conveying tensile strength and
transducing growth and survival signals. As upstream RISK
regulator,7,8,11 FAK reduces cell death by preventing mito-
chondrial perforation,5 which has been shown to protect
against IR injury in cardiac muscle.7,8 Conversely, reduced
FAK concentrations are considered hallmarks of impaired
tissue oxygenation,12 because FAK degradation is a natural
consequence of tissue ischemia.13 In skeletal muscle, FAKrelated effects of RISK activation and net mitochondrial
biogenesis have been conﬁrmed before.14,15
The aim of the present experimental pilot study was to
determine whether FAK expression was modulated by IR and
whether the enhancement of FAK expression had an impact
on apoptosis and inﬂammation in IR-injured skeletal muscle.
METHODS
A reality driven rodent model of acute hind limb ischemia16
was used to test whether enhanced FAK expression pro-
tected peripheral skeletal muscle from IR tissue injury. The
hypothesis was that protective FAK effects should be most
marked in muscle ﬁbers with low mitochondrial content,
because of their larger reserves towards an oxidative
shift.17 As in humans, rat fast-type glycolytic muscles (e.g.,
tibialis anterior and gastrocnemius muscles) have a lower
mitochondrial content than slow-type oxidative muscles
(i.e., soleus muscle).18
IR injury was compared across muscle phenotypes (i.e.,
gastrocnemius vs. soleus muscle) and the effect of
enhanced FAK expression was evaluated. For gene transfer,
the tibialis anterior was used as fast-type muscle because of
its preferred in vivo accessibility as described before.14,15 A
paired design was adopted to differentiate local IR injury
and protective effects from systemic reactions. Therefore,
contralateral limbs served as intra-individual controls
whereas external controls were subjected to ischemia only
(n ¼ 2) or sham treatment (n ¼ 4). Fig. 1B summarizes the
experiment.
308 M. Flück et al.Ethics and funding
All experiments were carried out in accordance with Prin-
ciples of Laboratory Animal Care (National Institutes of
Health publication 86e23, 1985) and after approval of the
animal protection and ethics commission of the Canton of
Bern, Switzerland. The study was supported by the Euro-
pean Society for Vascular Surgery (ESVS) 2013 research
grant.Ischemia reperfusion
Adult male Wistar rats (mean body weight 390  58 g) were
put under inhalation anesthesia (3e5% isoﬂurane)16 and
placed in supine position on a heating pad. A controlled
tension tourniquet was applied to the left limb in such a
way that after surgical isolation through a short groin inci-
sion it spared the femoral neurovascular bundle. Thereby,
subsequent arterial inﬂow was preserved for reperfusion.
Complete arterial ischemia was achieved by selective
clamping of the femoral artery whereas venous outﬂow was
maintained during ischemia.16 Ischemia (4 hours) was fol-
lowed by reperfusion for either 24 hours (n ¼ 14) or 72
hours (n ¼ 3). The above model characteristics were vali-
dated previously, as was the optimal timing of ischemia to
achieve near lethal injury with a preserved therapeutic
window.16 Analgesics (buprenorphin 50 mg/kg body weight)
were administered half an hour before the end of each
experiment and during postoperative follow up according to
a pain monitoring protocol.Muscle transfection
Somatic gene electrotransfer was used in the belly portion
of the soleus and tibialis anterior muscles as described.14,15Figure 2. Assessed endpoints in reperfused fast-type muscle. (A,B) Go
ischemic (B) limb of a reperfused gastrocnemius medialis muscle. Dam
irregular shape that deviates from the normal round appearance of m
sign of apoptosis in the non-ischemic (C) and ischemic (D) limb of a 24
Composite ﬁgure of example immunoblots detecting FAK (RISK pathw
inhibition of MTP opening, respectively), and CD68 protein (and the p
band serving as a loading control in the ischemic and non-ischemic limIn brief, plasmids were injected and their uptake was
stimulated by electropulses. For tibialis anterior muscle
120 ml of plasmid (at 1 mg/ml in Gibco water for injection)
was injected followed by eight trains of 60  100 ms pulses
at 50 mA (interrupted by 994 ms) at three locations using
needle electrodes on a GET42EV generator (GET42; EIP,
Jonzieux, France). For soleus muscle 70 ml of plasmid was
used followed by three trains of 80  100 ms pulses at
100 mA (interrupted by 992 ms) at two locations.
Muscle harvesting/handling
Muscles were rapidly excised under anesthesia and bluntly
separated, frozen in melting isopentane, and stored
at 80 C in sealed cryotubes. Subsequently, 12 mm sec-
tions were produced for histochemical analyses. In parallel,
cryosections were pooled for protein analyses. Transfection
efﬁciency was veriﬁed in randomly selected pCMV-FAK-
transfected specimens using immunohistochemical quanti-
ﬁcation of FAK protein content as described.15
Endpoint analysis
Rhabdomyolysis and apoptosis were quantiﬁed on muscle
cross sections after histological staining (rhabdomyolysis) or
DNA fragmentation (apoptosis). The degree of inﬂammation
was quantiﬁed using immunoblots for the macrophage
marker CD68 and veriﬁed by the immunohistochemistry for
CD68. The capacity to promote (BAX) or inhibit (Bcl-2)
mitochondrial transition pores was assessed in immuno-
blots. Representative examples are shown in Fig. 2.
Rhabdomyolysis. Sections were Goldner stained, and pro-
portions of intact versus lysed muscle ﬁbers were quantiﬁed
as described.19 In brief, microscopic ﬁelds (Eclipse TE2000-ldner staining visualizing lysed ﬁbers in the non-ischemic (A) and
aged muscle ﬁbers (reddish color, indicated by arrows) appear in
uscle ﬁbers. (C,D) TUNEL staining visualizing fragmented DNA as a
hours reperfused tibialis anterior muscle; Bars indicate 50 mm. (E)
ay member), BAX and Bcl-2 proteins (indicating promotion and
utative dimer CD682, indicating inﬂammation) including the actin
b of a reperfused tibialis anterior muscle.
Protective Effect of Focal Adhesion Kinase 309U, Nikon Instruments Europe BV, Amstelveen, the
Netherlands) were recorded at 10  magniﬁcation. Image J
software (http://imagej.nih.gov/ij/download) was used to
determine the proportion of lysed muscle ﬁbers to be
averaged for entire cross sections.
Apoptosis. Signs of nicked DNA (a typical sign of apoptosis)
were detected on cryosections with a terminal deoxy-
nucleotidyl transferase dUTP nick end-labeling (TUNEL)
assay (in situ cell death detection kit, Roche Diagnostics AG,
Rotkreuz, Switzerland). Subsequently, the number of TUNEL
positive nuclei was quantiﬁed per cross sectional area:
microscopic ﬁelds were recorded at 10 magniﬁcation in a
chessboard like manner avoiding ﬁeld overlap. Only ﬁelds
from central muscle sections were considered. Image J
software was used to determine the number of TUNEL
positive nuclei that demonstrated TUNEL (green) and nu-
clear stain (DAPI; blue) per microscopic ﬁeld. Subsequently,
TUNEL positive nuclei were averaged per area measured.
Inﬂammation. Inﬁltrating macrophages were detected by
immunohistochemistry for CD68. Inﬁltration, like the ca-
pacity to modulate mitochondrial transition pores, was
quantiﬁed using immunoblotting.
Immunoblotting. Total homogenates were denatured in
Laemmli sample buffer and separated using 12% SDSe
PAGE. Extract corresponding to 20 mg of total protein was
loaded per lane reﬂecting the paired design of the experi-
ment. Proteins were blotted onto a nitrocellulose mem-
brane and subjected to immunodetection with established
antibodies for FAK,20 Bcl-2, and BAX (#2870 and #2772, Cell
Signaling Technology, Allschwil, Switzerland), mitochondrial
proteins NDUFA9, SDHA, UQCRC1, COX4I1, ARP5A1 (Anti-
OxPhos complex kit, Molecular Probes, Invitrogen, Basel,
Switzerland), CD68 (MCA341R, AbD Serotec, Düsseldorf,
Germany), and horseradish peroxidase-coupled secondary
antibodies (GE Life Science, Glattbrugg, Switzerland). SignalFigure 3. Phenotype speciﬁc changes following ischemia reperfusion
graphs visualizing the mean  standard deviation (SD) of rhabdomyolys
FAK protein levels (C) in fast-type gastrocnemius and slow-type soleu
*p < 0.05 vs. 0 h of reperfusion (ANOVA with the post hoc Fisher teswas detected using a Femto chemiluminescent substrate
(Thermoscientiﬁc, Reinach, Switzerland), recorded on X-ray
ﬁlm (GE Life Science, Glattbrugg, Switzerland) and scanned
at 600 dpi into pdf format. Signal intensity was determined
using Image J. To assess relative concentrations, each
immunoblot was compared with a common sample.Statistics
Sample sizes were determined based on expected effect
sizes estimated from pilot experiments and minimized ac-
cording to the “reduceereplaceereﬁne” (3R) principle.
Local effects were assessed using multifactor-analysis of
variance (MANOVA) and Fisher post hoc tests for the fac-
tors “ischemic limb” (yes, no), “muscle type” (tibialis
anterior, gastrocnemius medialis and soleus muscle),
“ischemia reperfusion” (yes, no), and “plasmid” (pCMV,
pCMV-FAK0 as appropriate (Statistica 10, Statsoft, Tulsa,
USA). Systemic effects were assessed using MANOVA for
the factors “ischemia” (yes, no), “ischemic muscle” (yes,
no), and “muscle type”. Effects were assumed statistically
signiﬁcant at p < 0.05. Line graphs (rather than bars) were
used to visualize effects or differences between conditions.
Correlation analyses were carried out using Pearson’s
coefﬁcient.
RESULTS
Four of 29 rats (14%) died during the initial ischemic/pro-
cedural insult, but none died during subsequent reperfusion
or transfection, which was completed successfully in all
transfected animals (n ¼ 13). The expected oxidative phe-
notypes were reconﬁrmed: slow-type soleus muscle con-
tained more mitochondrial protein than tibialis anterior
(þ61  13%, p ¼ 0.03) or gastrocnemius medialis
(þ24  21%, p ¼ 0.08), respectively. Moreover, BAX protein
levels generally correlated well with rhabdomyolysis
(r ¼ 0.63, p < 0.001).regarding rhabdomyolysis, apoptosis and FAK protein levels. Line
is (A), apoptosis (expressed as area density of TUNEL signal; B), and
s muscle of the ischemic limb during the course of reperfusion.
t).
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In fast-type gastrocnemius muscle, rhabdomyolysis was
already marked after 24 hours following IR (12% vs. 0.7%
in paired controls, p ¼ 0.002; Fig. 3A and Supplementary
Fig. S1A). This ﬁnding persisted at 72 hours after IR. In
contrast, slow-type soleus muscle did not demonstrate
rhabdomyolysis at 24 hours of reperfusion, but only after
72 hours (3.1% vs. 0.7%, p ¼ 0.02). Apoptosis, however,
was elevated in soleus muscle after 24 hours of IR
(Fig. 3B)
Interestingly, BAX was not increased at 24 hours of
reperfusion, in either native fast-type (p ¼ 0.44) or native
slow-type muscles (p ¼ 0.77), compared with paired non-
ischemic controls (Supplementary Fig. S2).
Looking at systemic effects, no difference was noted
regarding rhabdomyolysis, apoptosis, or BAX levels in non-
ischemic muscles from experimental rats compared to
sham-treated animals (Supplementary Fig. S1).
Intrinsic FAK expression after reperfusion
FAK concentration was increased ﬁvefold 24 hours after IR
in fast-type muscle compared with paired controls
(p ¼ 0.002; Fig. 3C). A similar (although not statistically
signiﬁcant) trend was found in slow-type muscle (p ¼ 0.11).
There was an interaction between muscle type, ischemic
limb, and ischemia reperfusion (p ¼ 0.06) for FAK protein
levels, indicating that the effect of IR on intrinsic FAKFigure 4. Ischemia reperfusion injury in fast-type muscle (tibialis anterio
mean SD of FAK (A), BAX (C), Bcl-2 (D), and CD64 (F) protein levels, the
apoptosis (area density of the TUNEL, E) in transfected tibialis anterior mu
transfected non-ischemic limb; *p < 0.05 vs. pCMV-transfected ischemexpression depended on muscle type and on whether the
muscle was subjected to ischemia.Effects of enhanced FAK expression
pCMV-FAK transfection was effective in fast-type muscle,
where both ischemic and non-ischemic limbs showed
increased FAK concentrations (2.5-fold and 2.1-fold,
respectively) compared with empty plasmid-transfected
controls 24 hours after reperfusion (Fig. 4A). Conse-
quently, IR-induced rhabdomyolysis did not increase over
baseline level (i.e., over the level in the paired, non-
ischemic controls) in pCMV-FAK transfected fast-type
muscle (Fig. 4B). In contrast, empty plasmid-transfected
muscle, similar to native muscle, demonstrated increased
rhabdomyolysis compared to the paired, non-ischemic
controls with IR (Fig. 4B). Consistent with these ﬁndings,
IR-related BAX protein content was sixfold reduced
following pCMV-FAK transfection (Fig. 4C), whereas Bcl-2
and apoptosis were not affected by pCMV-FAK trans-
fection (Fig. 4D/E). Lastly, pCMV-FAK transfection produced
a reduction in the concentration of macrophage marker
CD68 in tibialis anterior muscle of the ischemic limb
(p ¼ 0.01), which was elevated with empty transfection
with IR (Fig. 4F).
In slow-type muscle, pCMV-FAK transfection did not in-
crease FAK protein concentrations (p¼ 0.66, compared with
empty plasmid controls), in either ischemic or non-ischemicr muscle) following FAK over expression. Bar graphs visualizing the
mean related percentage of rhabdomyolysis (B) and fold changes in
scle of the ischemic and non-ischemic limb. $p< 0.05 vs. the pCMV-
ic muscle, respectively (ANOVA with the Fisher post hoc test).
Protective Effect of Focal Adhesion Kinase 311controls (Fig. 5A). Consistently, FAK transfection did not
affect Bcl-2 (Fig. 5B), BAX (p ¼ 0.35) or CD68 protein levels
(p ¼ 0.69) after IR (data not shown). However, pCMV-FAK
transfection reduced apoptosis with IR (Fig. 5D). Trans-
fection with empty plasmid produced rhabdomyolysis in
ischemic and non-ischemic slow-type muscle to a similar
extent (13.7% and 12.3%, respectively, p ¼ 0.22) after 24
hours of IR.
DISCUSSION
IR injury is a fundamental and universal pathogenic process.
Unsurprisingly, it has attracted unparalleled attention within
cardiovascular research,3 which so far has focused mainly on
cardiac IR injury.5,21,22 As a consequence, management of
acute myocardial infarction has been revolutionized over the
years.8,9 Based on fundamental differences, these insights
may or may not be applicable to the clinical management of
acute limb ischemia. FAK’s protective effects on acutely
ischemic cardiac muscle7,23 primed the present hypothesis
driven investigation, which reconﬁrmed a similar effect in
fast-type skeletal muscle. Therefore, the present pilot ﬁnd-
ings may provide important impetus for research into prac-
tical salvage strategies that may be effective at least in a
portion of the musculature at risk.Figure 5. Ischemia reperfusion injury in slow-type muscle (soleus muscl
of FAK (A) and Bcl-2 (B) protein levels, the mean related percentage o
soleus muscle of the ischemic and non-ischemic limb. þ0.05 < p  0FAK is believed to convey a strong survival signal based
on the following observations: only rapid degradation of
FAK allows for apoptosis during ischemia7,8; FAK reacts with
a rebound increase upon reperfusion after ischemia13; and
this reaction may be maximized by repeated brief bouts of
ischemia (so called “pre-conditioning”), which seems highly
effective in protecting cardiac muscle from IR injury.7,9,24
The main ﬁndings of the present investigation support a
beneﬁcial effect of FAK in ischemic skeletal muscle, modu-
lated by the oxidative muscle phenotype (i.e., mitochondria
content). Using electro-assisted gene transfer, a muscle
type-speciﬁc disposition to express FAK was identiﬁed, as
well as differential effects of FAK on rhabdomyolysis and
modulators of mitochondrial transition pores (i.e., BAX, Bcl-
2). These protective biological effects appeared only in fast-
type muscle but not in slow-type muscle, which did not
respond to transfer with pCMV-FAK. Intriguingly, slow-type
muscle appeared naturally better protected against IR injury
than fast-type muscle. A manifest interpretation is that
mitochondria-poor skeletal muscle cells may beneﬁt more
from increased FAK levels because their functional reserves
for mitochondrial biogenesis are larger. In mice, for
instance, fast-type muscle ﬁbers present a lower mito-
chondrial content than slow-type muscle and appeare) with FAK over expression. Bar graphs visualizing the mean  SD
f rhabdomyolysis (C), fold changes in apoptosis (D) in transfected
.10 vs. pCMV (ANOVA with the Fisher post hoc test).
312 M. Flück et al.relatively protected by FAK,6,17 which is in line with the
postulated prevention of apoptosis by FAK.23 They ﬁndings
suggest that FAK reduces the expression of the transition
pore promoter BAX while enhancing mitochondrial
biogenesis via increased Bcl-2 levels. FAK signaling has been
described previously to stabilize mitochondria in culture by
up-regulating Bcl-2,25 and to counteract the adverse effects
of BAX, that is mitochondrial transition pore opening and
apoptosis.5 This effect was paralleled by a reduced number
of lysed muscle ﬁbers and the inﬂammation marker CD68,
which are known to increase with mitochondrial calcium
overload after IR injury when mitochondrial functioning is
inhibited (Fig. 1A). These combined effects make FAK a
promising candidate for skeletal muscle IR management, at
least in fast-type muscle.
In contrast, in muscle cells that are already rich in
mitochondria their upregulation may not have a corre-
sponding effect. In the present study, the relative inefﬁcacy
of FAK in slow-type muscle suggests that the prevention of
IR-induced lysis and apoptosis is graded by pre-existing
mitochondrial content,25 which could explain the
observed ceiling effect of FAK expression levels.
The severity of inﬂammation and rhabdomyolysis was
modulated consensually with FAK effects on apoptosis.
CD68-positive macrophages remove debris of damaged ﬁ-
bers26 thereby reducing escalation of inﬂammation. FAK
overexpression is known to enhance transcript levels of
immune cell markers.14 The ﬁndings of a reduction in BAX
and CD68 content and rhabdomyolysis indicate that FAK
overexpression lowers the degree of IR damage in tibialis
anterior muscle by affecting the inﬂammatory response.
Taken together, the present ﬁndings highlight the
importance of sustained (FAK-regulated) mitochondrial
integrity for salvage of ischemic skeletal muscle, which de-
pends on the oxidative phenotype. This may be exploited
therapeutically. For instance, an antibody therapy targeted
at beta-1-integrin, an upstream regulator of FAK phos-
phorylation,13,20 has been shown to protect tubular
epithelia against kidney IR injury by preserving their adhe-
sive cell state.13 And FAK overexpression is known to in-
crease the concentration of b1 integrin-based focal
adhesions in muscle ﬁbers,20 suggesting an important role
in the stabilization of muscle cell membranes.Strengths and limitations
A translational strength of the study is the realistic emula-
tion of arterial limb ischemia. Obstruction of the venous
outﬂow (and thus halted cellular respiration) is a typical
confounder of previous small animal (tourniquet) models of
limb ischemia, as is damage to the arterial inﬂow preventing
reliable in vivo assessment of reperfusion injury or treat-
ment effects.16,22,27 The present experiments circumvented
these limitations.16 Moreover, this model theoretically al-
lows intra-arterial application of therapeutic agents during
ischemia without affecting the femoral artery (i.e., via
cannulation of the epigastric artery). This could be relevant
for future experiments.The most important limitation is that FAK expression was
enhanced before onset of ischemia, which was due to the
proof of concept approach. However, in the clinical reality of
acute limb ischemia, post-conditioning approaches that are
effective in established ischemia are obviously needed. It is
known from cardiac research that therapeutic RISK activa-
tion protects ischemic cardiac muscle as long as it occurs
timely before reperfusion.10 Pharmacological measures
targeted at proximal integrin signaling as outlined above
may be of potential use for post-ischemia conditioning of
skeletal muscle and should be investigated in future
research. However, preconditioning is theoretically feasible
before iatrogenic ischemia, for instance during orthopedic
arthroplasty (arterial tourniquet) or peripheral revasculari-
zation, and might help in the mitigation of collateral IR
injury. Therefore, the present ﬁndings retain by all means a
concrete clinical relevance. Future research must aim at
assessing whether the damage response to IR is also graded
by mitochondrial reserves and FAK protein levels in humans
and whether the aerobic phenotype of muscles being
affected by IR may help reﬁning priorities during surgical
interventions to prevent irreversible muscle damage.
Another limitation is that experiments were designed to
assess the impact of FAK on cellular IR injury endpoints
rather than on underlying signaling pathways. Thereby,
contralateral limbs were used as controls for inﬂammatory
markers. Although these muscles showed no difference to
sham treated controls, IR could have affected them by
systemic effects, thereby confounding the postulated FAK-
mediated protection. But even if that was the case, the
true difference between ischemic and non-ischemic muscle
would have been underestimated, which strengthens the
conclusions. All ﬁndings, albeit in line with the study hy-
pothesis and previous experimental evidence, are based on
modest numbers of biological replicas, which might affect
statistical power. As the experiments were set up as a pilot
study to evaluate salvage pathways known to be effective in
myocardial infarction, they aimed to comply with the de-
mands of the 3R principle. To control the multiple biological
factors, assessed time points were limited according to
established IR injury kinetics in this model.16 Last but not
least, potentially important factors such as intracellular
calcium metabolism were not controlled, which could
confound any conclusions. Despite these limitations, the
experiments produced consistent, plausible, and statistically
signiﬁcant results suggesting that the extent of skeletal
muscle IR injury was modiﬁed by muscle phenotype and
could be mitigated by enhanced FAK expression. Arguably,
biological effects after IR seem particularly complex in pe-
ripheral muscle and the investigated therapeutic approach
was not effective in all muscle types.
In conclusion, the present ﬁndings suggest a modulatory
role of the oxidative muscle phenotype in IR-induced
rhabdomyolysis, which is likely to correlate with muscle ﬁ-
ber mitochondria content. The identiﬁed protective effect
of enhanced FAK expression is fast-type muscle speciﬁc and
offers a potential therapeutic approach to reduce reperfu-
sion induced rhabdomyolysis preserving muscle function.
Protective Effect of Focal Adhesion Kinase 313For clinical beneﬁt, appropriate strategies must be identi-
ﬁed that are effective while ischemia is already established
and could be included in post conditioning protocols before
conclusions regarding translational potential and clinical
relevance can be drawn.CONFLICT OF INTEREST
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